In vitro 3D cell-based assays as alternatives to animal testing.
| Date | Round | Amount |
|---|---|---|
| Feb 2024 | Funding round Newcastle-based Newcells Biotech raised £2.35M from the North East Venture Fund and Northstar Ventures for its 3D cell models. | $3M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.